Back to Search

ROBERT ROSENSON, MD

MD

Cardiovascular Disease Physician

NPI: 1760407449IndividualAccepts Medicare

Specialties, Licenses & Credentials

Cardiovascular Disease PhysicianPrimary

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

253461(NY)

CMS Specialties

PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)

Education

TULANE UNIVERSITY SCHOOL OF MEDICINE

Class of 1983

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease

NCT03829046COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects.
PMID 38583289·Atherosclerosis·2024
2-rct
Cholesterol, inflammation and innate immunity.
PMID 25614320·Nat Rev Immunol·2015
6-review
Profiling inflammatory responses with microfluidic immunoblotting.
PMID 24312374·PLoS One·2013
7-preclinical
Monocytes: protagonists of infarct inflammation and repair after myocardial infarction.
PMID 20530020·Circulation·2010
6-review
Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior.
PMID 17599600·J Am Coll Cardiol·2007
6-review
Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature.
PMID 15466704·Proc Natl Acad Sci U S A·2004
8-other
Management of non-high-density lipoprotein abnormalities.
PMID 19545870·Atherosclerosis·2009
6-review
Role of the endocannabinoid system in abdominal obesity and the implications for cardiovascular risk.
PMID 19641317·Cardiology·2009
6-review
Treatment of hypertension in metabolic syndrome subjects with amlodipine and olmesartan-effects on oxidized non-esterified free fatty acids and cytokine production.
PMID 19641984·Cardiovasc Drugs Ther·2009
4-observational
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.
PMID 19332472·Circulation·2009
6-review
A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN.
PMID 19361346·Curr Atheroscler Rep·2009
8-other
Vascular biomarkers in the metabolic syndrome.
PMID 19379078·Expert Rev Mol Diagn·2009
8-other
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial.
PMID 19231633·Lancet·2009
3-trial
Management of hyperlipidemia in older adults.
PMID 19124599·J Cardiovasc Pharmacol Ther·2009
6-review
Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease.
PMID 19153679·Cardiovasc Drugs Ther·2009
6-review
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
PMID 19204302·Circulation·2009
4-observational
Triglycerides and cardiovascular events in ACS: the need for combined lipid-altering therapies.
PMID 19079366·Nat Clin Pract Cardiovasc Med·2009
8-other
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
PMID 19389575·J Am Coll Cardiol·2009
6-review
Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.
PMID 19023279·Obesity (Silver Spring)·2009
2-rct
Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study.
PMID 19265025·Diabetes Care·2009
2-rct

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
1190 5TH AVE
NEW YORK, NY 10029

Locations (2)

Practice Location

1190 5TH AVE, NEW YORK, NY
(212) 427-1540

Practice Location

1 GUSTAVE L LEVY PL, NEW YORK, NY
(212) 427-1540

Quick Facts

NPI
1760407449
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
2
Years in Practice
43
Clinical Trials
1
Publications
20

Are you this provider?

Claim Your Profile